Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography | 23 | 2022 | 458 | 3.690 |
Why?
|
| Abscess | 7 | 2021 | 78 | 3.280 |
Why?
|
| Point-of-Care Systems | 11 | 2022 | 122 | 3.030 |
Why?
|
| Emergency Medicine | 10 | 2021 | 182 | 2.680 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 6 | 2023 | 46 | 2.470 |
Why?
|
| Heart Arrest | 5 | 2023 | 161 | 2.390 |
Why?
|
| Drainage | 6 | 2021 | 150 | 1.890 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2023 | 85 | 1.740 |
Why?
|
| Advanced Cardiac Life Support | 3 | 2022 | 14 | 1.300 |
Why?
|
| Respiratory Insufficiency | 5 | 2013 | 148 | 1.240 |
Why?
|
| Dichlorvos | 5 | 2013 | 15 | 1.210 |
Why?
|
| Ultrasonography, Interventional | 4 | 2017 | 92 | 1.190 |
Why?
|
| Organophosphate Poisoning | 4 | 2013 | 14 | 1.180 |
Why?
|
| Fellowships and Scholarships | 3 | 2021 | 98 | 1.180 |
Why?
|
| Soft Tissue Infections | 3 | 2017 | 45 | 1.100 |
Why?
|
| Apnea | 3 | 2013 | 30 | 0.910 |
Why?
|
| Prospective Studies | 16 | 2022 | 3067 | 0.890 |
Why?
|
| Respiratory Center | 2 | 2013 | 3 | 0.870 |
Why?
|
| Education, Medical, Graduate | 5 | 2016 | 317 | 0.810 |
Why?
|
| Staphylococcal Skin Infections | 2 | 2014 | 13 | 0.810 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2014 | 62 | 0.760 |
Why?
|
| Clinical Competence | 6 | 2015 | 683 | 0.730 |
Why?
|
| Adrenergic Agents | 2 | 2018 | 15 | 0.730 |
Why?
|
| Emergency Service, Hospital | 7 | 2021 | 1022 | 0.710 |
Why?
|
| Rats, Wistar | 11 | 2014 | 179 | 0.690 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2013 | 45 | 0.690 |
Why?
|
| Physical Examination | 2 | 2018 | 104 | 0.650 |
Why?
|
| Treatment Failure | 6 | 2021 | 185 | 0.650 |
Why?
|
| Echocardiography | 5 | 2023 | 457 | 0.630 |
Why?
|
| Humans | 41 | 2024 | 59389 | 0.590 |
Why?
|
| Internship and Residency | 6 | 2015 | 747 | 0.580 |
Why?
|
| Regional Blood Flow | 2 | 2014 | 108 | 0.540 |
Why?
|
| Male | 27 | 2018 | 27749 | 0.530 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2014 | 43 | 0.510 |
Why?
|
| Organophosphates | 2 | 2013 | 16 | 0.510 |
Why?
|
| Insecticides | 3 | 2012 | 30 | 0.490 |
Why?
|
| Learning Curve | 1 | 2015 | 30 | 0.480 |
Why?
|
| Hypoxia | 2 | 2014 | 112 | 0.470 |
Why?
|
| Rats | 10 | 2013 | 1910 | 0.460 |
Why?
|
| Atropine | 1 | 2014 | 13 | 0.450 |
Why?
|
| Decision Trees | 1 | 2014 | 51 | 0.450 |
Why?
|
| Dehydration | 1 | 2014 | 15 | 0.450 |
Why?
|
| Pulmonary Ventilation | 1 | 2014 | 37 | 0.450 |
Why?
|
| Blood Volume | 1 | 2014 | 42 | 0.440 |
Why?
|
| Certification | 1 | 2014 | 46 | 0.440 |
Why?
|
| Carotid Arteries | 1 | 2014 | 62 | 0.440 |
Why?
|
| Fluid Therapy | 1 | 2014 | 47 | 0.440 |
Why?
|
| Bronchodilator Agents | 1 | 2014 | 122 | 0.410 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 1091 | 0.410 |
Why?
|
| Parathion | 1 | 2012 | 5 | 0.400 |
Why?
|
| Point-of-Care Testing | 2 | 2022 | 44 | 0.390 |
Why?
|
| Soybean Oil | 1 | 2012 | 31 | 0.390 |
Why?
|
| Adult | 15 | 2021 | 15681 | 0.380 |
Why?
|
| Phospholipids | 1 | 2012 | 78 | 0.380 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2012 | 37 | 0.380 |
Why?
|
| Lung | 3 | 2022 | 920 | 0.380 |
Why?
|
| Radiology | 1 | 2015 | 236 | 0.360 |
Why?
|
| Brain Stem | 1 | 2011 | 28 | 0.360 |
Why?
|
| Sleep Apnea, Central | 1 | 2011 | 7 | 0.360 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 61 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 2 | 2006 | 735 | 0.330 |
Why?
|
| Female | 17 | 2018 | 30726 | 0.330 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2009 | 21 | 0.320 |
Why?
|
| Abdomen | 2 | 2006 | 91 | 0.320 |
Why?
|
| United States | 8 | 2021 | 7426 | 0.320 |
Why?
|
| Vagotomy | 1 | 2009 | 8 | 0.320 |
Why?
|
| Sorption Detoxification | 1 | 2009 | 1 | 0.320 |
Why?
|
| Liver Transplantation | 2 | 2009 | 207 | 0.310 |
Why?
|
| Vena Cava, Inferior | 1 | 2009 | 28 | 0.310 |
Why?
|
| Skin Diseases | 1 | 2009 | 76 | 0.300 |
Why?
|
| Gallbladder Diseases | 1 | 2008 | 25 | 0.300 |
Why?
|
| Acute Disease | 4 | 2013 | 658 | 0.290 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 94 | 0.280 |
Why?
|
| Retrospective Studies | 6 | 2021 | 6071 | 0.280 |
Why?
|
| Infant | 4 | 2017 | 1492 | 0.270 |
Why?
|
| Ludwig's Angina | 1 | 2006 | 1 | 0.270 |
Why?
|
| Middle Aged | 9 | 2018 | 16314 | 0.260 |
Why?
|
| Child, Preschool | 4 | 2017 | 1793 | 0.260 |
Why?
|
| Radiography, Abdominal | 1 | 2006 | 26 | 0.260 |
Why?
|
| Pesticides | 1 | 2007 | 55 | 0.260 |
Why?
|
| Flank Pain | 1 | 2005 | 8 | 0.250 |
Why?
|
| Cystitis | 1 | 2005 | 9 | 0.250 |
Why?
|
| Staphylococcus | 1 | 2005 | 16 | 0.250 |
Why?
|
| Gram-Negative Bacteria | 1 | 2005 | 54 | 0.250 |
Why?
|
| Aged | 6 | 2018 | 13408 | 0.240 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2006 | 53 | 0.240 |
Why?
|
| Drug Resistance | 1 | 2005 | 95 | 0.240 |
Why?
|
| Urinary Tract Infections | 1 | 2006 | 80 | 0.240 |
Why?
|
| Animals | 12 | 2014 | 19650 | 0.230 |
Why?
|
| Kidney Diseases | 1 | 2005 | 169 | 0.220 |
Why?
|
| Ketamine | 1 | 2024 | 32 | 0.210 |
Why?
|
| Central Nervous System Depressants | 1 | 2024 | 42 | 0.210 |
Why?
|
| Reoperation | 2 | 2018 | 272 | 0.210 |
Why?
|
| Ultrasonography, Doppler | 1 | 2023 | 24 | 0.210 |
Why?
|
| Child | 5 | 2017 | 4189 | 0.210 |
Why?
|
| Societies, Medical | 2 | 2016 | 337 | 0.210 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 5119 | 0.190 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2024 | 140 | 0.190 |
Why?
|
| Drug Overdose | 1 | 2024 | 126 | 0.190 |
Why?
|
| Young Adult | 3 | 2018 | 4272 | 0.190 |
Why?
|
| Data Collection | 1 | 2023 | 371 | 0.180 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2021 | 37 | 0.180 |
Why?
|
| Escherichia coli | 1 | 2006 | 695 | 0.180 |
Why?
|
| Heart Failure | 1 | 2009 | 853 | 0.180 |
Why?
|
| Adolescent | 4 | 2017 | 5838 | 0.180 |
Why?
|
| Respiration | 2 | 2013 | 88 | 0.180 |
Why?
|
| Electric Countershock | 1 | 2021 | 99 | 0.180 |
Why?
|
| Magnetics | 1 | 2001 | 53 | 0.180 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 2516 | 0.180 |
Why?
|
| Benchmarking | 1 | 2021 | 135 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2014 | 914 | 0.170 |
Why?
|
| Faculty, Medical | 1 | 2021 | 192 | 0.160 |
Why?
|
| Organophosphorus Compounds | 2 | 2013 | 31 | 0.160 |
Why?
|
| Heart Rate | 2 | 2014 | 307 | 0.160 |
Why?
|
| Time Factors | 4 | 2016 | 3617 | 0.160 |
Why?
|
| Intubation, Intratracheal | 1 | 2001 | 194 | 0.160 |
Why?
|
| Telemedicine | 1 | 2024 | 308 | 0.150 |
Why?
|
| Electrocardiography | 1 | 2021 | 523 | 0.150 |
Why?
|
| Disease Models, Animal | 5 | 2013 | 2050 | 0.150 |
Why?
|
| Curriculum | 2 | 2015 | 560 | 0.150 |
Why?
|
| Blood Pressure | 2 | 2014 | 496 | 0.150 |
Why?
|
| Epinephrine | 1 | 2017 | 41 | 0.140 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 61 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2017 | 5283 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1559 | 0.140 |
Why?
|
| Survival Analysis | 2 | 2016 | 554 | 0.130 |
Why?
|
| Canada | 1 | 2016 | 147 | 0.130 |
Why?
|
| Pneumothorax | 1 | 2016 | 49 | 0.130 |
Why?
|
| Confidence Intervals | 2 | 2014 | 241 | 0.130 |
Why?
|
| Tissue Donors | 2 | 2009 | 143 | 0.130 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 155 | 0.110 |
Why?
|
| Registries | 1 | 2017 | 801 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 206 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 409 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2015 | 212 | 0.110 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 131 | 0.110 |
Why?
|
| Community-Acquired Infections | 1 | 2014 | 92 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 931 | 0.110 |
Why?
|
| Diphenhydramine | 2 | 2003 | 9 | 0.100 |
Why?
|
| Histamine H1 Antagonists | 2 | 2003 | 10 | 0.100 |
Why?
|
| Nerve Net | 1 | 2013 | 93 | 0.100 |
Why?
|
| Respiratory Mechanics | 1 | 2012 | 57 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2013 | 230 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 589 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2006 | 2338 | 0.100 |
Why?
|
| ROC Curve | 1 | 2012 | 267 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 805 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2006 | 1284 | 0.090 |
Why?
|
| Microdialysis | 1 | 2011 | 5 | 0.090 |
Why?
|
| Respiratory Rate | 1 | 2011 | 14 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2012 | 355 | 0.090 |
Why?
|
| Tidal Volume | 1 | 2011 | 37 | 0.090 |
Why?
|
| Jugular Veins | 1 | 2010 | 29 | 0.090 |
Why?
|
| Logistic Models | 1 | 2014 | 1234 | 0.090 |
Why?
|
| Oxygen | 1 | 2012 | 313 | 0.090 |
Why?
|
| Methyl Parathion | 1 | 2010 | 3 | 0.090 |
Why?
|
| Models, Anatomic | 1 | 2010 | 60 | 0.090 |
Why?
|
| Aryldialkylphosphatase | 1 | 2010 | 18 | 0.090 |
Why?
|
| Critical Care | 1 | 2014 | 397 | 0.080 |
Why?
|
| Abdominal Injuries | 1 | 2010 | 29 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2010 | 84 | 0.080 |
Why?
|
| Competency-Based Education | 1 | 2009 | 28 | 0.080 |
Why?
|
| Subcutaneous Tissue | 1 | 2009 | 14 | 0.080 |
Why?
|
| Cellulitis | 1 | 2009 | 22 | 0.080 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2009 | 34 | 0.080 |
Why?
|
| Employment | 1 | 2010 | 124 | 0.080 |
Why?
|
| Hemochromatosis | 1 | 2009 | 6 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 103 | 0.080 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2009 | 5 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2009 | 36 | 0.080 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2009 | 19 | 0.080 |
Why?
|
| Vagus Nerve | 1 | 2009 | 20 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 37 | 0.080 |
Why?
|
| Emulsions | 1 | 2012 | 457 | 0.080 |
Why?
|
| Massachusetts | 1 | 2014 | 2019 | 0.070 |
Why?
|
| Optic Nerve | 1 | 2008 | 25 | 0.070 |
Why?
|
| Dyspnea | 1 | 2009 | 116 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 1507 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 705 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2009 | 189 | 0.070 |
Why?
|
| Anesthesia, Inhalation | 1 | 2007 | 14 | 0.070 |
Why?
|
| Blood Gas Analysis | 1 | 2007 | 34 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 167 | 0.070 |
Why?
|
| Anesthesia, General | 1 | 2007 | 43 | 0.070 |
Why?
|
| Periodontal Abscess | 1 | 2006 | 1 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 81 | 0.070 |
Why?
|
| Imino Acids | 1 | 2006 | 3 | 0.070 |
Why?
|
| Utilization Review | 1 | 2006 | 31 | 0.070 |
Why?
|
| Gallstones | 1 | 2006 | 24 | 0.070 |
Why?
|
| Cholecystitis | 1 | 2006 | 27 | 0.070 |
Why?
|
| Videotape Recording | 1 | 2006 | 46 | 0.070 |
Why?
|
| Patient Selection | 1 | 2009 | 465 | 0.060 |
Why?
|
| Skin | 1 | 2009 | 357 | 0.060 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 57 | 0.060 |
Why?
|
| Colic | 1 | 2005 | 2 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 276 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 191 | 0.060 |
Why?
|
| Hematuria | 1 | 2005 | 19 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2006 | 95 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 516 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 292 | 0.060 |
Why?
|
| Diazepam | 1 | 2003 | 10 | 0.060 |
Why?
|
| Muscle Relaxants, Central | 1 | 2003 | 12 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2005 | 304 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 255 | 0.050 |
Why?
|
| Glycopyrrolate | 1 | 2003 | 23 | 0.050 |
Why?
|
| Muscarinic Antagonists | 1 | 2003 | 32 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2003 | 56 | 0.050 |
Why?
|
| Algorithms | 1 | 2007 | 974 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 692 | 0.040 |
Why?
|
| Equipment Design | 1 | 2001 | 329 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 257 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 1119 | 0.040 |
Why?
|
| Lung Injury | 1 | 2016 | 32 | 0.030 |
Why?
|
| Random Allocation | 2 | 2003 | 192 | 0.030 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 13 | 0.020 |
Why?
|
| Manikins | 1 | 2010 | 19 | 0.020 |
Why?
|
| Lethal Dose 50 | 1 | 2010 | 14 | 0.020 |
Why?
|
| Punctures | 1 | 2010 | 56 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 75 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2010 | 70 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 101 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2010 | 133 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1238 | 0.020 |
Why?
|
| Physicians | 1 | 2010 | 440 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 2375 | 0.010 |
Why?
|
| Ipratropium | 1 | 2003 | 7 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 2003 | 33 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 221 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 486 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 1027 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2004 | 814 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 1504 | 0.010 |
Why?
|